IP Library Patent Application 16496597
Patent Application
App. No. 16/496,597

CONTROLLED RELEASE OF PHASEOLAMIN COMPOSITIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/496,597
Abstract

The invention is directed to a controlled release composition containing phaseolamin and a mineral, where the mineral is bound by a glycoprotein matrix. The composition may also contain stabilizers and/or additives and/or microorganisms.

Claims (25)

1 . A controlled release composition comprising phaseolamin, a mineral, and microorgansims, wherein said mineral is bound by a glycoprotein matrix, wherein said microorganisms produce said glycoprotein matrix, and wherein said microorganisms include yeast and bacteria.

2 . A composition according to claim 1 , wherein said yeast includes Saccharomyces cervisiae.

3 . A composition according to claim 1 , wherein said bacteria includes Lactobacillus.

4 . A composition according to claim 3 , wherein said bacteria includes Lactobacillus acidophillus or Bacterium bifidus.

5 . A composition according to claim 1 , further comprising stabilizers and/or additives.

6 . A composition according to claim 1 , wherein said composition is added to a baking mix.

7 . A composition according to claim 6 , wherein said baking mix is selected from the group consisting of pancake, waffle, bread, biscuit and cookie mix.

8 . A composition according to claim 6 , wherein said mineral is vanadium or chromium or both.

9 . A composition according to claim 6 , wherein the controlled release is selected from the group consisting of diffusion, dissolution, osmotic, ion-exchange, floating, bio-adhesive, stimuli inducing and matrix.

10 . A method for inhibiting absorption of dietary starch in a host, said method comprising administering to said host, an effective amount of a controlled release composition comprising phaseolamin and a mineral, and wherein said mineral is bound by a glycoprotein matrix.

11 . A method according to claim 10 , wherein said composition further comprises microorganisms.

12 . A method according to claim 11 , wherein said microorganisms produce said glycoprotein matrix.

13 . A method according to claim 11 , wherein said microorganisms include yeast.

14 . A method according to claim 13 , wherein said yeast includes Saccharomyces cervisiae.

15 . A method according to claim 11 , wherein said microorganisms include bacteria.

16 . A method according to claim 15 , wherein said bacteria includes Lactobacillus.

17 . A method according to claim 16 , wherein said bacteria includes Lactobacillus acidophillus or Bacterium bifidus.

18 . A method according to claim 11 , wherein said microorganisms include yeast and bacteria.

19 . A method according to claim 10 , further comprising stabilizers and/or additives.

20 . A method according to claim 10 , wherein said dietary starch is amylose.

21 . A method according to claim 10 , wherein said host is a human.

22 . A method according to claim 10 , wherein said human is obese.

23 . A method according to claim 22 , wherein said human is morbidly obese.

24 . A method according to claim 21 , wherein said human suffers from an impairment of glucose utilization.

25 . A method according to claim 24 , wherein said impairment of glucose utilization is diabetes mellitus.

Assignments (3)
SECURITY AGREEMENT Recorded Aug 30, 2024
From: PHARMACHEM LABORATORIES LLC
To: SIENA LENDING GROUP LLC
Reel/Frame 068822/0698 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2024
From: MUSA, OSAMA M.; GHOSH, MOUSUMI; GEBRESELASSIE, PETROS; OTHS, PHILIP JOHN
To: ISP INVESTMENTS LLC
Reel/Frame 067239/0218 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2019
From: SKOP, MITCH
To: PHARMACHEM LABORATORIES, INC
Reel/Frame 050458/0913 →